Evoke Pharma Inc Share Price: EVOK (Evoke Pharma Inc) Stock Price Today & Updates | INDmoney

Question 1

What is Evoke Pharma Inc share price today?

Accepted Answer

Evoke Pharma Inc (EVOK) share price today is {{live_price}}.

Question 2

Can Indians buy Evoke Pharma Inc shares?

Accepted Answer

Yes, Indians can invest in the Evoke Pharma Inc (EVOK) from India.

With INDmoney, you can buy Evoke Pharma Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Evoke Pharma Inc at zero transaction cost.

Question 3

How can I buy Evoke Pharma Inc shares from India?

Accepted Answer

It is very easy to buy Evoke Pharma Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Evoke Pharma Inc be purchased?

Accepted Answer

Yes, you can buy fractional shares of Evoke Pharma Inc with INDmoney app.

Question 5

What are the documents required to start investing in Evoke Pharma Inc stocks?

Accepted Answer

To start investing in Evoke Pharma Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Evoke Pharma Inc

Accepted Answer

Today’s highest price of Evoke Pharma Inc (EVOK) is {{1_rba_end}}.

Today’s lowest price of Evoke Pharma Inc (EVOK) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Evoke Pharma Inc

Accepted Answer

Today's market capitalisation of Evoke Pharma Inc EVOK is 4.4M

Question 8

What is the 52 Week High and Low Range of Evoke Pharma Inc

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Evoke Pharma Inc is down from its 52 Week High?

Accepted Answer

Evoke Pharma Inc (EVOK) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Evoke Pharma Inc is up from its 52 Week low?

Accepted Answer

Evoke Pharma Inc (EVOK) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Evoke Pharma Inc?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Evoke Pharma Inc

Accepted Answer

Mr. Matthew J. D'Onofrio MBA is the current Chief Executive Officer (CEO) of Evoke Pharma Inc.

Period	Evoke Pharma Inc	Index (Russel 2000)
3 Months	-10.14%	0.0%
6 Months	0.92%	0.0%
1 Year	-61.74%	0.0%
3 Years	-96.94%	-23.0%

Market Capitalization	4.4M
Book Value	$3.63
Earnings Per Share (EPS)	-15.89
PEG Ratio	-0.1
Wall Street Target Price	18.0

Profit Margin	-86.75%
Operating Margin TTM	-47.96%

Return On Assets TTM	-36.8%
Return On Equity TTM	-407.6%

Revenue TTM	7.5M
Revenue Per Share TTM	10.24
Quarterly Revenue Growth YOY	125.49999999999999%
Gross Profit TTM	2.1M
Diluted Eps TTM	-15.89
Quarterly Earnings Growth YOY	0.0

Evoke Pharma Inc (EVOK)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Increasing Revenue

Increasing Net Profit

Vs CTLT

Vs NBIX

Institutional Holdings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-2.42
EPS Estimate Next Year	0.24
EPS Estimate Current Quarter	-0.72
EPS Estimate Next Quarter	0.12

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Evoke Pharma Inc	4.75%	0.92%	-61.74%	-96.94%	-95.33%
Neurocrine Biosciences Inc.	0.22%	-11.71%	9.36%	13.47%	21.32%
Haleon Plc Spon Ads	-5.08%	20.69%	22.01%	36.17%	36.17%
Zoetis Inc.	-0.16%	32.8%	16.08%	-7.35%	52.85%
Viatris Inc.	2.53%	4.53%	31.84%	-16.06%	-28.03%
Catalent, Inc.	0.9%	7.56%	42.8%	-54.43%	23.98%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Evoke Pharma Inc	0.04	NA	-0.1	-2.42	-4.08	-0.37	NA	3.63
Neurocrine Biosciences Inc.	35.55	35.55	0.27	4.54	0.16	0.12	NA	24.87
Haleon Plc Spon Ads	32.52	32.52	1.5	0.39	0.07	0.04	0.02	1.82
Zoetis Inc.	37.9	37.9	2.64	5.83	0.49	0.14	0.01	10.94
Viatris Inc.	224.4	NA	0.07	2.67	-0.03	0.03	0.04	16.36
Catalent, Inc.	211.02	NA	3.02	0.2	-0.25	0.0	NA	19.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Evoke Pharma Inc	Buy	$4.4M	-95.33%	0.04	-86.75%
Neurocrine Biosciences Inc.	Buy	$11.9B	21.32%	35.55	16.0%
Haleon Plc Spon Ads	Buy	$45.6B	36.17%	32.52	9.66%
Zoetis Inc.	Buy	$87.6B	52.85%	37.9	26.29%
Viatris Inc.	Hold	$14.0B	-28.03%	224.4	-4.24%
Catalent, Inc.	Hold	$10.9B	23.98%	211.02	-23.81%

Organization	Evoke Pharma Inc
Employees	4
CEO	Mr. Matthew J. D'Onofrio MBA
Industry	Health Technology